Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Snapshot of Japanese Pre-Clincal Outsourcing Market 2016" report to their offering.
This report discusses about the preclinical outsourcing market in Japan, specifically focusing on preclinical service providers with animal testing capability for pharmaceutical companies.
The preclinical market peaked in 2008, and started to decline afterward. We estimate the market size in 2015 was almost the same as 2010 or even below.
Most players are dedicated to the preclinical services. While local players such as SNBL and Ina Research still show significant presence in Japan, global firms such as Charles River and Harlan have been showing prominence gradually over the years.
We estimate the market size would remain flat or slightly decrease over the years. While local firms barely hold on in the mean time, we anticipate global firms will take the leading role in the long run, with wider regional reach and service offerings.
Key Topics Covered:
1. Summary
2. Market Overview
3. Industry Association
4. Key Local Players
5. Global Players
6. Future Prospect
Companies Mentioned
- Charles River
- Harlan
- Ina Research
- SNBL
For more information about this report visit http://www.researchandmarkets.com/research/2fmnhx/snapshot_of
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Consulting and Outsourcing


Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Bank of America's $72.5M Epstein Settlement: What You Need to Know
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



